We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Thomas Habermann

Thomas M. Habermann MD

Professor of Medicine, Mayo Clinic College of Medicine; Associate Dean, Mayo School of Graduate Medical Education, Rochester, Minnesota

Thomas M. Habermann M.D. is a Professor of Medicine at Mayo Clinic College of Medicine and Associate Dean at the Mayo School of Graduate Medical Education.

He attended Creighton University for his undergraduate degree and earned his medical degree at Creighton University.  He completed Internal Medicine training at Mayo Clinic.  He completed a Hematology fellowship at Mayo Clinic and subsequently joined the faculty in 1985 at Mayo Clinic Rochester.

Dr. Habermann has dedicated a career to clinical research.  He was Chair of the Mayo Clinic Lymphoma Group for 14 years.  He was the principal investigator of the Mayo Clinic ECOG Mayo U-10 Grant since 1993-2014, a co-investigator on the University of Iowa/Mayo Clinic Lymphoma SPORE Grant serving as the Co-Director of the Clinical Trials Core.  He has been involved in 17 drugs in clinical trials that include five drugs before their FDA approved indications.  He has been involved in collaborations with James Cerhan, M.D., PhD in clinical epidemiology, SNP analyses, and a collaborator on whole exome studies with Margaret Shipp, M.D. at the Dana Farber Cancer Center and the Broad Institute in diffuse large B-cell lymphoma.